Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06012656 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Eligibility criteria expanded, about 15 words Secondary endpoints: details revised at 3 of 6 entries Show 1 more changeShow less
    • Secondary endpoints: details revised at 3 of 6 entries
  2. Site details revisedv3
  3. Study title expanded, about 1 wordv2 See this version in full on ClinicalTrials.gov ↗
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a post-marketing surveillance on MiniMAX Stem
Trial Details
NCT Number NCT06012656
Lead Sponsor Medacta International SA
Conditions Primary Osteoarthritis, Secondary Osteoarthritis, Traumatic Arthritis, Rheumatoid Arthritis, Congenital Hip Dysplasia, Avascular Necrosis, Fracture; Femur, Head
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov